Group
IV (Carnosine-Amikacin group): Animals were simultaneously treated with carnosine and amikacin with the previously mentioned doses for 2 weeks.
Drugs :
Carnosine was obtained as ampoules produced by MEPACO, Egypt.
Amikacin was obtained as amikin ampoule produced by Bristol-Myers Squib Company, Egypt.
At the end of the experiment, the animals were fasted overnight (12-14 hs). Heparinized blood samples were obtained for separation of plasma to make biochemical analyses. Then, the rats were decapitated and the kidneys were collected for histopathological study.
Chemical analysis:
Serum levels of blood urea nitrogen (BUN) and Creatinine were determined using the Olympus Autoanalyser (Olympus Instruments, Tokyo, Japan).
Histopathological studies:
The kidneys of each animal were removed. Small pieces of fresh tissue were fixed in 10% neutral formalin and processed. Paraffin sections 5µm thick were stained with hematoxylin and eosin. The Many antioxidants aimed to prevent free radicals from harmfully oxidizing tissues. However, most antioxidants have no effect after the first line of defense is broken (Hipkiss et al., 1997) .
As antioxidants could be useful in reducing the nephrotoxicity of aminoglycosides, the current work was conducted to study the possible protective role of carnosine on amikacin-induced nephrotoxicity in rats.
MATERIAL AND METHODS

Animals :
Eighty adult male albino rats with an average weight of 200 grams were allocated into four groups of 20 animals each as follows:
Group I (Negative control group): Animals were injected with 1 ml isotonic saline as a daily subcutaneous dose for 2 weeks.
Group II (Positive control group): Animals were injected with a daily subcutaneous dose of carnosine "10 mg/kg" for 2 weeks (Soliman et al., 2002) .
Group III (Amikacin group):
Animals were injected with a daily subcutaneous dose of amikacin "30 mg/kg" double the therapeutic dose (Brunton et al., 2006) for 2 weeks.
capsule. Other glomeruli showed degeneration and loss of their cells with haemorrhagic areas. The convoluted tubules showed cloudy swelling of their lining epithelium with narrowed lumens. In addition, there were necrotic changes in the form of pale cytoplasm, karyolysis and pyknosis in their epithelial cells. There were numerous haemorrhagic areas in between the tubules and partial loss of the basement membranes with loss of brush borders of the tubules. There was cellular infiltration in some segments of the cortex near the glomeruli. There were periglomerular and peritubular connective tissue thickening. Some collecting tubules showed necrotic and degenerative changes in the form of pale cytoplasm, pyknosis and karyolysis. There were small numerous haemorrhagic areas in between tubules. The tubules showed partial loss of their basement membranes (Figs. 4-7 ). There were intertubular spaces denoting edema. The collecting tubules showed swollen epithelial cells with narrowing or obliteration of their lumens (Fig. 8) .
Histopathological examination of the renal sections of Group IV (carnosineamikacin group) revealed some normal glomeruli with intact basement membranes of their Bowman's capsules. Other glomeruli were deformed. The convoluted tubules showed intact basement membranes. However, there was cloudy swelling of the lining epithelium of some conhistopathological changes were evaluated in several sections from each group.
Statistical analysis
Student's-t test was used for the evaluation of statistical significance. Difference was considered significant at P < 0.05 level. All values were expressed as mean + SD.
RESULTS
Regarding the biochemical study, amikacin administration induced significant increases of blood urea and serum creatinine concentrations in amikacin group. On the other hand, these 2 parameters were not affected by carnosine treatment. Furthermore, simultaneous administration of carnosine with amikacin significantly attenuated the impairment of renal function (Table 1 & Fig. 1) . Indeed, the increases of plasma urea and creatinine concentrations were significantly reduced in this group compared to amikacin group.
Histopathological examination of the renal sections in groups I and II revealed normal glomeruli united by little connective tissue (Figs. 2, 3 ). On the other hand, group III showed glomerular congestion and loss or narrowing of Bowman's space. Some glomeruli were deformed in shape. In other glomeruli, there was widening of Bowman's space. There was also partial loss of basement membrane of Bowman's creases tissue toxicity (Parlakpinar et al., 2003) . Nowadays, it has been beleived that aminoglycosides-induced nephrotoxicity is not a simple process, and that many mechanisms are involved including increased urinary losses of carnitine (AlShabanah et al., 2010) .
Carnosine, an antioxidant, was shown to be an important protective factor in human diabetes (Janssen et al., 2005) and to have curative action on hypercholesterolemia-induced kidney insult which were proved to be a consequence of oxidative stress (Soliman et al., 2004) .
As amikacin-induced nephrotoxicity may be the consequence of oxidative stress and so antioxidant agents could be useful in reducing amikacin nephrotoxicity. Based on this concept, the current study was conducted to evaluate the protective effect of carnosine in amikacininduced nephrotoxicity in a rat model.
The results of the present study revealed that there was a biochemical alteration of measured renal function tests and morphological changes, including glomerular, tubular epithelial alterations and interstitial edema, in amikacin-treated rats. These findings are in agreement with many previous studies which reported that patients developed nephrotoxicity when they administered aminoglycosides for long duration and when they received voluted tubules with narrowed lumens. The collecting tubules in renal medulla showed normal histological structure (Figs. 9, 10) .
DISCUSSION
Aminoglycosides nephrotoxicity, functional and morphological, is well established. Amikacin has proved to posses serious nephrotoxic side effects which may end in acute renal failure. Moreover, it was reported that amikacin-induced nephrotoxicity was not significantly dependent on dosing frequency and one injection of 1 gm was followed by extensive renal damage with severe alteration of the renal function (Sweileh, 2009).
It was early believed that the nephrotoxicity results from retention and accumulation of aminoglycosides in the proximal tubular cells (Aronof et al., 1983) . In addition, Schnackenberg (2002) reported that the free radicals are responsible for the enhanced vascular tone and tubuloglomerular degeneration of the kidney which is the pathogenesis of the oxidative stress associated with diabetes mellitus, hypertension and aminoglycosides nephrotoxicity.
It is well established that some agents such as aminoglycosides generate free oxygen radicals, leading to an increased oxireductase production, which in turn in-with aminoglycosides therapy attenuates the renal damage and protects the kidney from the oxidative degenerative changes (Chen and Tappel 1995; Pedraza-Chaverri et al., 2003; Mehri et al., 2005) .
The protective ability of carnosine could be explained by the following mechanisms: first, it was proved that carnosine preserves the membrane fluidity (Rusakov et al., 1993) . Second, it had cytosolic buffering action (Quinn et al., 1992) . Third, it ameliorates the toxic decrease of antioxidants like glutathione, catalase, and superoxide dismutase (Soliman and Saba-El Rigal, 2004) , and finally it acts as an efficient reactive oxygen species (ROS) scavenger (Swearengin et al., 1999) .
Uniquely, carnosine was proved to posses a double antioxidant action; scavenging ROS, preventing lipid peroxidation of cell membranes, and regaining those already oxidized (Hipkiss and Chana, 1998) . It is to be mentioned that, except carnosine, no other antioxidant was proved to have the ability to regain the already oxidized lipids.
On the other hand, carnosine was reported to selectively stimulate proteins and enzymes (Soliman and Ali, 2004 ), which in turn may produce direct effects on many cellular enzymes (Kuleva and Zalesova, 2000) . In addition, it preserves protein functional properties via large total dose of aminoglycosides (Chambers, 2001; De Jager and Van Altena, 2002; Wiland and Szechcinski, 2003; Parlakpinar et al., 2006) .
On the other hand, the coadministration of carnosine with amikacin in the experimental animals was accompanied by marvelous improvement of the levels of BUN and serum creatinine. This is in accordance with Parlakpinar et al. (2006) who established that administration of antioxidants before amikacin injection caused significant improvement in function of the kidney compared to rats treated with amikacin alone. This was confirmed by Brunton et al. (2006) who stated that the impairment in renal function is almost always reversible because the proximal tubular cells have the capacity to regenerate.
Histopathological examination of renal sections in group IV showed that the majority of the glomeruli were normal in structure with intact basement membranes of their Bowman's capsules. The convoluted tubules have intact basement membranes and thin peritubular connective tissue. Some convoluted tubules were ballooned and have pale cytoplasm. The collecting tubules of the renal medulla were normal, although ballooning was seen in few cells. These findings are supported by the previous studies which reported that the addition of antioxidants suppress histamine release from mast cells, which is a part of the inflammatory reaction. Protecting the cells from the deleterious transformation of both lipids and protein molecules, carnosine could preserve molecular cell constituents and organelles thus, decreasing apoptosis (Hipkiss et al., 2002 ).
In conclusion, carnosine could be useful for reducing the nephrotoxic effects of amikacin. Further studies are needed to elucidate the mechanisms of protective effect of carnosine.
preventing the combination of deleterious radicals with protein molecules as well as removing already formed harmful protein products by forming non-functional protein-carbonyl-carnosine complexes which are gotten rid of by lysosomes (Hipkiss et al., 2002) . Furthermore, carnosine was proved to have an immunostimulatory action with increased natural immune response via stimulating the growth factors and cytokines, which promotes tissue recovery (Hobart et al., 2004) . Moreover, it was also reported that carnosine has an anti-inflammatory effect by its ability to Mansoura J. Forensic Med. Clin. Toxicol. 
